Literature DB >> 15257300

BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

Pietro Pichierri1, Annapaola Franchitto, Filippo Rosselli.   

Abstract

Fanconi anaemia (FA) and Bloom syndrome (BS) are autosomal recessive diseases characterised by chromosome fragility and cancer proneness. Here, we report that BLM and the FA pathway are activated in response to both crosslinked DNA and replication fork stall. We provide evidence that BLM and FANCD2 colocalise and co-immunoprecipitate following treatment with either DNA crosslinkers or agents inducing replication arrest. We also find that the FA core complex is necessary for BLM phosphorylation and assembly in nuclear foci in response to crosslinked DNA. Moreover, we show that knock-down of the MRE11 complex, whose function is also under the control of the FA core complex, enhances cellular and chromosomal sensitivity to DNA interstrand crosslinks in BS cells. These findings suggest the existence of a functional link between BLM and the FA pathway and that BLM and the MRE11 complex are in two separated branches of a pathway resulting in S-phase checkpoint activation, chromosome integrity and cell survival in response to crosslinked DNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257300      PMCID: PMC514912          DOI: 10.1038/sj.emboj.7600277

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

Review 1.  Mechanisms and consequences of replication fork arrest.

Authors:  O Hyrien
Journal:  Biochimie       Date:  2000-01       Impact factor: 4.079

2.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway.

Authors:  Andreas Rothfuss; Markus Grompe
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 4.  The Fanconi anemia pathway and the DNA interstrand cross-links repair.

Authors:  Filippo Rosselli; Delphine Briot; Pietro Pichierri
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

5.  A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.

Authors:  Q Waisfisz; J P de Winter; F A Kruyt; J de Groot; L van der Weel; L M Dijkmans; Y Zhi; F Arwert; R J Scheper; H Youssoufian; M E Hoatlin; H Joenje
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  Sensitivity of Bloom syndrome fibroblasts to mitomycin C.

Authors:  G J Hook; E Kwok; J A Heddle
Journal:  Mutat Res       Date:  1984 May-Jun       Impact factor: 2.433

7.  Homologous recombination resolution defect in werner syndrome.

Authors:  Yannick Saintigny; Kate Makienko; Cristina Swanson; Mary J Emond; Raymond J Monnat
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest.

Authors:  Sally L Davies; Phillip S North; Alwyn Dart; Nicholas D Lakin; Ian D Hickson
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.

Authors:  Pietro Pichierri; Filippo Rosselli
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

10.  Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks.

Authors:  Albert R Davalos; Judith Campisi
Journal:  J Cell Biol       Date:  2003-09-29       Impact factor: 10.539

View more
  58 in total

1.  MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability.

Authors:  Mei Leng; Doug W Chan; Hao Luo; Cihui Zhu; Jun Qin; Yi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 2.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 3.  Fanconi anaemia: from a monogenic disease to sporadic cancer.

Authors:  Antonio Valeri; Sandra Martínez; José A Casado; Juan A Bueren
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 4.  Unwinding protein complexes in ALTernative telomere maintenance.

Authors:  Saumitri Bhattacharyya; April Sandy; Joanna Groden
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

Review 5.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 6.  The BLM dissolvasome in DNA replication and repair.

Authors:  Kelly A Manthei; James L Keck
Journal:  Cell Mol Life Sci       Date:  2013-03-31       Impact factor: 9.261

Review 7.  Susceptibility pathways in Fanconi's anemia and breast cancer.

Authors:  Alan D D'Andrea
Journal:  N Engl J Med       Date:  2010-05-20       Impact factor: 91.245

Review 8.  Hitting the bull's eye: novel directed cancer therapy through helicase-targeted synthetic lethality.

Authors:  Monika Aggarwal; Robert M Brosh
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

9.  Bloom syndrome radials are predominantly non-homologous and are suppressed by phosphorylated BLM.

Authors:  Nichole Owen; James Hejna; Scott Rennie; Asia Mitchell; Amy Hanlon Newell; Navid Ziaie; Robb E Moses; Susan B Olson
Journal:  Cytogenet Genome Res       Date:  2015-02-28       Impact factor: 1.636

10.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.